Fideuram Asset Management Ireland dac Purchases New Shares in Procter & Gamble Company (The) $PG

Fideuram Asset Management Ireland dac purchased a new stake in shares of Procter & Gamble Company (The) (NYSE:PG) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 42,789 shares of the company’s stock, valued at approximately $6,132,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of PG. Brighton Jones LLC raised its holdings in Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after buying an additional 13,617 shares during the period. Taylor Financial Group Inc. raised its holdings in Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock valued at $493,000 after buying an additional 277 shares during the period. Sivia Capital Partners LLC raised its holdings in Procter & Gamble by 19.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock valued at $979,000 after buying an additional 1,016 shares during the period. Auxano Advisors LLC raised its holdings in Procter & Gamble by 10.8% during the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock valued at $1,165,000 after buying an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. raised its holdings in Procter & Gamble by 2.8% during the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after buying an additional 809 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

PG opened at $146.07 on Friday. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $170.99. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44. The business’s fifty day simple moving average is $144.47 and its 200-day simple moving average is $147.92. The company has a market capitalization of $340.14 billion, a price-to-earnings ratio of 21.36, a PEG ratio of 6.32 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.03. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.The business had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the prior year, the company earned $1.54 EPS. The business’s revenue was up 7.4% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Friday, April 24th were given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, April 24th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s dividend payout ratio is currently 63.60%.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: One article highlights P&G as a potentially solid long-term buy, suggesting the company still has attractive fundamentals despite some valuation caveats. Procter & Gamble: A Solid ‘Buy’ With Some Caveats
• Positive Sentiment: P&G was included in a broader list of battered blue-chip dividend stocks, which may support investor interest in the stock’s defensive income profile. 5 Battered Blue-Chip Stocks That Pay Huge Dividends and Won’t Be Down Forever
• Neutral Sentiment: Several comparisons and reassessment pieces on P&G versus Clorox, and whether P&G is still attractive after its recent share-price decline, could influence sentiment but do not point to a clear fundamental catalyst. Procter & Gamble vs. Clorox: Which Consumer Goods Stock Is a Better Buy in 2026? Procter & Gamble vs. Clorox: Which Consumer Goods Stock Is a Better Buy in 2026? Is It Time To Reassess Procter & Gamble (PG) After A 12% One Year Share Price Decline
• Neutral Sentiment: P&G also announced that CFO Andre Schulten will speak at Deutsche Bank’s consumer conference on June 3, which is a routine investor-relations update rather than a major business development. P&G to Webcast Presentation From the Deutsche Bank dbAccess Global Consumer Conference, June 3
• Neutral Sentiment: Coverage of former P&G CMO Jim Stengel being honored at an industry event is a reputational mention, but it is unlikely to affect the stock. AAF 75th Hall of Fame: Former P&G CMO Jim Stengel Honored for Advertising Impact
• Negative Sentiment: Some commentary argues P&G is priced too richly relative to growth, which may be weighing on shares as investors question upside from current valuation levels. Procter & Gamble: Priced Like A Hyper-Growth Tech Stock

Analyst Ratings Changes

A number of analysts have weighed in on the company. BNP Paribas Exane reduced their target price on Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating on the stock in a research note on Thursday, April 23rd. Barclays reduced their target price on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Piper Sandler increased their target price on Procter & Gamble from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Friday, April 24th. Morgan Stanley reduced their target price on Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group reduced their target price on Procter & Gamble from $179.00 to $175.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $161.06.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.